Oral PI3K-δ,γ Inhibitor for the Management of People with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Narrative Review on Duvelisib

Shah A, Barrientos JC

OncoTargets and Therapy 2021, 14:2109-2119

Published Date: 25 March 2021